ClinicalTrials.Veeva

Menu

Incidence of Diarrhea Using High and Low Osmolality Enteral Tube Feeding in Critically Ill Surgical Patients

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Terminated

Conditions

Tube Feeding

Treatments

Other: Promote without fiber
Other: Osmolite 1.5

Study type

Interventional

Funder types

Other

Identifiers

NCT03487744
IRB_00108798

Details and patient eligibility

About

The purpose and primary objective of this study is to determine if there is an association between enteral tube feed (TF) osmolality and diarrhea in critically ill patients. The investigators hypothesize that the administration of a TF formulation with high osmolality will cause more diarrhea than a TF formulation with a lower osmolality.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age >18 years
  • admitted to SICU or CVICU requiring TF for enteral nutrition
  • anticipated ICU stay and TF requirement >72 hours

Exclusion criteria

  • Contraindication to receiving one of the study TF formulations
  • Inability to tolerate at least 75% of estimated requirement by day 3 of enteral TF administration
  • Clostridium difficile infection or other cause of infectious diarrhea prior to study enrollment
  • Presence of an ileostomy or colostomy
  • History of inflammatory bowel disease, bowel resection, short gut syndrome, or chronic diarrhea

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Promote without fiber
Active Comparator group
Description:
Lower osmolality enteral tube feed formulation
Treatment:
Other: Promote without fiber
Osmolite 1.5
Active Comparator group
Description:
Higher osmolality enteral tube feed formulation
Treatment:
Other: Osmolite 1.5

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems